...
首页> 外文期刊>European review for medical and pharmacological sciences. >Effects of rosuvastatin on neuronal apoptosis in cerebral ischemic stroke rats via Sirt1/NF-kappa B signaling pathway
【24h】

Effects of rosuvastatin on neuronal apoptosis in cerebral ischemic stroke rats via Sirt1/NF-kappa B signaling pathway

机译:罗苏伐他汀通过Sirt1 /NF-κB信号通路对脑缺血性中风大鼠神经元凋亡的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To investigate the effects of rosuvastatin on nerve cell apoptosis in rats with cerebral ischemic stroke through Sirt1/NF-κB pathway. MATERIALS AND METHODS: 30 model rats were divided into three groups: normal group, stroke group (rats with cerebral ischemic stroke) and stroke+RVT group (cerebral ischemic stroke rats treated with rosuvastatin). The expression of Sirt1/NF-κB, areas of stroke infarction, cell cycles, as well as apoptosis situation in different groups were detected by Western Blot, immunohistochemistry, histomorphological observation, triphenyl tetrazolium chloride (TTC) staining and flow cytometry as well as immunofluorescent staining. RESULTS: Optical microscope observation showed cells in normal group presented complete and clear cellular hierarchical structure, regular cell arrangement, bluish violet cell nucleus and pink cytoplasm. No damage or necrosis was observed under normal condition. In stroke group, the boundary line between cytoplasm and nucleus was blurry and some apoptosis bodies were also observed. However, after rosuvastatin treatment, necrosis disappeared in stroke+RVT group. Western Blot analysis showed that the expression of SIRT1 decreased and NF-κB elevated in stroke group compared with those in normal group (p0.05). However, rosuvastatin could reverse the effects of stroke on SIRT1 and NF-κB (p0.05). The results of immunohistochemistry and immunofluorescent staining also confirmed our findings in SIRT1 and NF-κB expression after stroke. The areas of cerebral infarction increased significantly in stroke group and this effect could also be reversed by rosuvastatin treatment (p0.05). Besides, cell cycle detection also showed that rosuvastatin treatment could inhibit the shortening of G1, S as well as G2 periods in cell cycles after stoke (p0.05). CONCLUSIONS: Rosuvastatin may have great effects on improving cerebral infarction condition in rats with cerebral ischemic stroke. The mechanisms may be through Sirt1/ NF-κB pathway, thereby reducing the apoptosis rate and improving cell cycle of brain cells.
机译:目的:研究瑞舒伐他汀通过Sirt1 /NF-κB途径对脑缺血性中风大鼠神经细胞凋亡的影响。材料与方法:30只模型大鼠分为三组:正常组,中风组(脑缺血性中风大鼠)和中风+ RVT组(罗苏伐他汀治疗脑缺血性中风大鼠)。通过Western Blot,免疫组织化学,组织形态学观察,三苯基氯化四唑(TTC)染色和流式细胞术以及免疫荧光检测Sirt1 /NF-κB的表达,中风梗塞区域,细胞周期以及不同组的凋亡情况。染色。结果:光学显微镜观察发现正常组细胞呈现完整清晰的细胞层级结构,规则的细胞排列,蓝紫色细胞核和粉红色细胞质。正常情况下未观察到损伤或坏死。脑卒中组细胞质与细胞核的界线模糊,并观察到一些凋亡小体。然而,瑞舒伐他汀治疗后,卒中+ RVT组坏死消失。 Western Blot分析显示,卒中组SIRT1表达降低,NF-κB表达升高,与正常组相比差异有统计学意义(p <0.05)。然而,瑞舒伐他汀可以逆转中风对SIRT1和NF-κB的影响(p <0.05)。免疫组化和免疫荧光染色的结果也证实了我们在卒中后SIRT1和NF-κB表达中的发现。脑卒中组脑梗死面积明显增加,瑞舒伐他汀治疗也可逆转这种作用(p <0.05)。此外,细胞周期检测还显示,瑞舒伐他汀处理可抑制卒中后细胞周期的G1,S和G2周期缩短(p <0.05)。结论:瑞舒伐他汀可能对改善脑缺血性中风大鼠的脑梗死状况有重要作用。其机制可能是通过Sirt1 /NF-κB途径,从而降低了细胞的凋亡率并改善了脑细胞的细胞周期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号